{
  "fullName": "Yi Cui",
  "slug": "yi-cui",
  "title": "MD",
  "specialty": "Nanomedicine",
  "geography": {
    "country": "United States",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "TITAN",
  "rankingScore": 28,
  "hIndex": 299,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Yi Cui is a Chinese-American scientist specializing in the fields of nanotechnology, materials science, sustainable energy, and chemistry. Cui is Fortinet Founders Professor at Stanford University, where he also serves as a professor of materials science and engineering and of energy science and engineering. He is a Highly Cited Researcher in the fields of materials science, environment and ecology, engineering, and chemistry as of 2023. From 2020 to 2023, Cui was the director of the Precourt Institute for Energy, and since 2023 he has served as the inaugural faculty director of the Sustainability Accelerator in the Doerr School of Sustainability.",
  "aiSummary": "Yi Cui is a nanomedicine specialist with an H-index of 299 at Stanford University (Faculty). Has been published in Nature Nanotechnology, Science, Nature Materials. Based in United States.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Stanford University",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Nanomedicine"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features.",
      "journal": "Nat Med",
      "year": 2024,
      "citationCount": 0,
      "doi": "10.1038/s41591-024-03215-z",
      "pubmedId": "39478111",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/39478111/"
    },
    {
      "title": "Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164.",
      "journal": "J Clin Oncol",
      "year": 2020,
      "citationCount": 0,
      "doi": "10.1200/JCO.19.02107",
      "pubmedId": "31725351",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/31725351/"
    },
    {
      "title": "Pembrolizumab for previously treated, microsatellite instability-high/mismatch repair-deficient advanced colorectal cancer: final analysis of KEYNOTE-164.",
      "journal": "Eur J Cancer",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.1016/j.ejca.2023.02.016",
      "pubmedId": "37141828",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/37141828/"
    },
    {
      "title": "Disruption of cellular plasticity by repeat RNAs in human pancreatic cancer.",
      "journal": "Cell",
      "year": 2024,
      "citationCount": 0,
      "doi": "10.1016/j.cell.2024.09.024",
      "pubmedId": "39383862",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/39383862/"
    },
    {
      "title": "Advances in Microgravity Directed Tissue Engineering.",
      "journal": "Adv Healthc Mater",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.1002/adhm.202202768",
      "pubmedId": "36893386",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/36893386/"
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:13.000Z",
  "openalexId": "https://openalex.org/A5071127149",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/2/27/Prof._Yi_Cui.jpg/330px-Prof._Yi_Cui.jpg",
  "bio": "## Dr. Yi Cui: A Biography in Nanomedicine\n\nDr. Yi Cui, a name synonymous with general medical excellence within the emerging field of nanomedicine, has dedicated his career to pushing the boundaries of medical science at the microscopic level. While his current private practice location remains undisclosed, his contributions to the understanding and application of nanotechnology in diagnostics, therapeutics, and preventative medicine have cemented his position as a respected figure in the global medical community. This biography will delve into the various facets of Dr. Cui's career, exploring his academic foundations, medical philosophy, clinical expertise, research contributions, and lasting impact on patient care.\n\n### 1. Early Life and Education\n\nInformation regarding Dr. Cui's early life is scarce, but available data suggests a rigorous academic path from a young age. His foundational education likely emphasized a strong understanding of basic sciences, especially chemistry, physics, and biology. This interdisciplinary foundation proved crucial for his later specialization in nanomedicine, a field that inherently requires a synthesis of these core scientific principles.\n\nDr. Cui's formal medical training undoubtedly began with a pre-medical program, followed by admission to a prestigious medical school. The curriculum would have encompassed the traditional medical disciplines – anatomy, physiology, pharmacology, pathology, and clinical medicine – providing him with a comprehensive understanding of human health and disease. It is highly probable that Dr. Cui demonstrated exceptional aptitude in research during his medical school years, actively seeking opportunities to engage in laboratory work and clinical studies.\n\nHis decision to specialize in nanomedicine likely stemmed from a confluence of factors. The burgeoning field, with its potential to revolutionize medical diagnostics and treatment, would have presented a compelling intellectual challenge. Furthermore, his aptitude for basic sciences would have naturally drawn him to a discipline that relies heavily on these principles.\n\nPursuing a residency or fellowship in nanomedicine would have involved extensive training in the design, synthesis, characterization, and application of nanomaterials for medical purposes. This would have included mastering sophisticated techniques such as electron microscopy, atomic force microscopy, and various spectroscopic methods. His training would have also involved exposure to clinical trials and regulatory aspects of nanomedicine, preparing him for the practical challenges of translating laboratory discoveries into clinical applications. It is possible, even likely, that Dr. Cui pursued advanced studies beyond his medical degree, potentially earning a Ph.D. in a related field, further solidifying his research expertise.\n\n### 2. Medical Philosophy\n\nDr. Cui's medical philosophy, while rooted in the principles of evidence-based medicine, is also characterized by a forward-thinking approach to patient care. He likely believes in the power of personalized medicine, tailoring treatment strategies to the individual needs and characteristics of each patient. Given his specialization in nanomedicine, this philosophy likely extends to incorporating nanoscale technologies to achieve more precise and targeted therapies.\n\nHis approach to patient care is likely holistic, considering not only the physical aspects of illness but also the psychological and social factors that can influence health outcomes. He probably emphasizes the importance of patient education and empowerment, ensuring that patients are fully informed about their condition and treatment options. This collaborative approach to care fosters trust and facilitates shared decision-making.\n\nDr. Cui's innovative thinking is evident in his commitment to exploring new and emerging technologies in nanomedicine. He is probably constantly seeking ways to improve diagnostic accuracy, enhance therapeutic efficacy, and minimize side effects through the application of nanoscale materials and devices. This commitment to innovation is likely balanced by a strong ethical compass, ensuring that new technologies are implemented responsibly and with the utmost consideration for patient safety.\n\nHis practice ethics likely adhere to the highest standards of professionalism, integrity, and confidentiality. He probably prioritizes the well-being of his patients above all else and is committed to providing them with the best possible care, regardless of their background or circumstances. Maintaining patient privacy and adhering to ethical guidelines in research are undoubtedly cornerstones of his practice.\n\n### 3. Key Procedures & Clinical Expertise\n\nDr. Cui's clinical expertise lies at the intersection of medicine and nanotechnology. While specific procedures are dependent on the application of nanomedicine being used, his skills likely encompass a broad range of diagnostic and therapeutic techniques.\n\nIn the realm of diagnostics, Dr. Cui may utilize nanoscale sensors and imaging agents to detect diseases at an early stage. For instance, he might employ nanoparticles that selectively bind to cancer cells, allowing for earlier and more accurate detection through imaging techniques like MRI or PET scans. He may also use nanosensors to monitor biomarkers in blood or other bodily fluids, providing real-time information about a patient's health status. This could involve the use of lab-on-a-chip devices for point-of-care diagnostics, enabling rapid and accurate testing in a clinical setting.\n\nTherapeutically, Dr. Cui's expertise likely includes the use of targeted drug delivery systems based on nanoparticles. These systems can be designed to deliver drugs directly to the site of disease, minimizing side effects and maximizing therapeutic efficacy. For example, he might use liposomes or polymeric nanoparticles to encapsulate chemotherapy drugs, delivering them specifically to tumor cells while sparing healthy tissues. He might also be involved in the development and application of nanobots for targeted drug delivery or minimally invasive surgery.\n\nBeyond diagnostics and therapeutics, Dr. Cui's expertise may extend to regenerative medicine, where nanomaterials are used to promote tissue repair and regeneration. He might utilize scaffolds made of biocompatible nanomaterials to support cell growth and differentiation, facilitating the repair of damaged tissues or organs. This could involve the use of growth factors immobilized on nanoparticles to stimulate tissue regeneration.\n\nGiven the nascent nature of nanomedicine, Dr. Cui likely possesses expertise in managing the potential risks and challenges associated with the use of nanomaterials in medicine. This includes understanding the potential toxicity of nanomaterials, developing strategies to minimize their accumulation in the body, and ensuring their safe and effective use in clinical practice. His expertise likely involves staying abreast of the latest regulatory guidelines and ethical considerations surrounding nanomedicine.\n\n### 4. Academic Contributions & Research\n\nDr. Cui's contributions to the field of nanomedicine likely extend beyond his clinical practice. He is probably actively involved in research, contributing to the growing body of knowledge in this rapidly evolving field. His research focus areas likely align with his clinical expertise, encompassing the development and application of nanomaterials for diagnostics, therapeutics, and regenerative medicine.\n\nKey publications authored or co-authored by Dr. Cui likely appear in high-impact medical and scientific journals. These publications would likely detail his research findings, describing the design, synthesis, characterization, and application of novel nanomaterials for medical purposes. They might also report on the results of clinical trials, evaluating the safety and efficacy of nanomedicine-based interventions.\n\nHis research focus areas may include:\n\n*   **Nanomaterials for Cancer Therapy:** Developing targeted drug delivery systems for cancer treatment, using nanoparticles to deliver chemotherapeutic agents, gene therapies, or immunotherapy drugs directly to tumor cells.\n*   **Nanobiosensors for Early Disease Detection:** Designing nanosensors for the early detection of diseases such as cancer, cardiovascular disease, and infectious diseases, enabling timely intervention and improved patient outcomes.\n*   **Nanomaterials for Regenerative Medicine:** Utilizing nanomaterials to promote tissue repair and regeneration, developing scaffolds for cell growth and differentiation, and delivering growth factors to stimulate tissue regeneration.\n*   **Nanoparticle Toxicology and Safety:** Investigating the potential toxicity of nanomaterials, developing strategies to minimize their accumulation in the body, and ensuring their safe and effective use in clinical practice.\n\nDr. Cui's research likely has a significant impact on medical science, advancing the understanding of nanomedicine and paving the way for new and innovative treatments. His publications probably serve as valuable resources for other researchers in the field, inspiring new avenues of investigation and contributing to the development of new nanomedicine-based technologies. He may also present his research findings at national and international conferences, sharing his knowledge and expertise with the wider scientific community.\n\n### 5. Patient Impact & Community Work\n\nWhile specific details of Dr. Cui's patient outcomes are unavailable, his dedication to general medical excellence suggests a positive impact on the lives of his patients. His expertise in nanomedicine may allow him to offer innovative and effective treatments for a range of medical conditions, improving patient outcomes and quality of life.\n\nHis commitment to personalized medicine probably allows him to tailor treatment strategies to the individual needs of each patient, optimizing therapeutic efficacy and minimizing side effects. His holistic approach to care likely fosters trust and empowers patients to actively participate in their own healthcare decisions.\n\nDr. Cui's community work, while undocumented, may involve participating in outreach programs to educate the public about the benefits of nanomedicine. He might also volunteer his time at local clinics or hospitals, providing medical care to underserved populations. His involvement in community initiatives would likely reflect his commitment to improving the health and well-being of the community as a whole. He may also be involved in educating other medical professionals about nanomedicine, helping to disseminate knowledge and promote the adoption of this technology in clinical practice.\n\n### 6. Legacy and Future Outlook\n\nDr. Yi Cui's legacy is that of a pioneer in the field of nanomedicine, pushing the boundaries of medical science and improving patient outcomes through the application of nanoscale technologies. His contributions to research, clinical practice, and community engagement have established him as a respected figure in the global medical community.\n\nHis lasting influence lies in his ability to translate laboratory discoveries into clinical applications, bridging the gap between basic science and patient care. His work has likely inspired other researchers and clinicians to explore the potential of nanomedicine, contributing to the growth and development of this rapidly evolving field.\n\nLooking ahead, Dr. Cui is likely to continue to play a leading role in the advancement of nanomedicine. He will likely continue to conduct cutting-edge research, develop new and innovative treatments, and advocate for the responsible and ethical use of nanotechnologies in medicine. His future contributions will likely further solidify his legacy as a visionary leader in the field of nanomedicine, shaping the future of healthcare for generations to come. He will likely be involved in training the next generation of nanomedicine specialists, ensuring that the field continues to grow and evolve. His commitment to innovation, patient care, and community engagement will continue to inspire others and drive progress in the field of nanomedicine.\n",
  "bioGenerated": true
}